Dr. Reddy's Laboratories Limited (RDY) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.08T |
| Enterprise Value | 1.14T |
| P/E Ratio | 41.27 |
| PEG Ratio | -0.79 |
| Price/Sales Ratio | 3.5 |
| Price/Book Ratio | 2.99 |
| Enterprise/Revenue | 3.68 |
| Enterprise/EBITDA | 20.41 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 353.47B |
| Revenue/Share | 395.82 |
| Gross Profit | 186.52B |
| EBITDA | 83.29B |
| Net Income | 45.09B |
| Diluted EPS | 53.92 |
Balance Sheet
| Total Cash | 76.58B |
| Total Cash/Share | 91.49 |
| Total Debt | 72.6B |
| Total Debt/Equity | 0.19 |
| Current Ratio | 1.93 |
| Book Value Per Share | 467.26 |
Price History
| 52-Week Change | 7.15 |
| 52-Week High | 15.67 |
| 52-Week Low | 11.36 |
| Moving Average 50 Days | 12.94 |
| Moving Average 200 Days | 13.27 |
Statistics
| Average Volume | 2.92M |
| Shares Outstanding | 833.07M |
| % Held by Institutions | 15.08 |
Dividend And Splits
| Trailing Annual Dividend Rate | 8 |
| Trailing Annual Dividend Yield | 0.58 |
| Payout Ratio | 0.24 |
| Last Split Factor | 5:1 |
| Last Split Date | November 05, 2024 |
AD
